Keyword: Drug Development

News

Ashland Opens Newest Pharmaceutical Center of Excellence

21.10.2014 - On September 30, Ashland Specialty Ingredients opened a state-of-the-art pharmaceutical center of excellence in Wilmington. The new facility will focus on drug development and...

Strategy & Management

Discovering the Future of Pharma

30.09.2014 - Dramatic changes to the scientific and business environments have made it impossible for pharmaceutical companies to continue operating as they have in the past. A perceived...

News

Recipharm and Isofol Medical in Exclusive Drug Development

29.08.2014 - Two Swedish drugmakers, Recipharm and Isofol Medical, have agreed to collaborate to strengthen the development program of Isofol's lead drug candidate Modufolin, an endogenous...

News

AMRI acquires Cedarburg Pharmaceuticals

26.03.2014 - AMRI announced that it has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals for US$38.2 million in cash. The transaction, including US$2...

News

Sanofi and Munich University to Cooperate on Drug Development

24.03.2014 - French drugmaker Sanofi has agreed to form a three-year strategic partnership on drug development with Ludwig-Maximilians-University and the university clinic of Munich, Germany...

News

Merck Serono in Spanish Drug Development Pact

23.12.2013 - Merck Serono, the biopharmaceuticals division of Germany's Merck KGaA, has signed a global license agreement with the Spanish National Research Center (CNIO) in Madrid on cancer...

Plant Construction & Process Technology

Outsourcing Biopharmaceutical Manufacturing

12.11.2013 - Development On Trial - The number of biopharmaceutical projects in clinical trials and products is increasing, playing an important role in new treatments. Many of these projects...

Plant Construction & Process Technology

Rethinking Biosimilar Development

08.11.2013 - The World's Biologics Drug Price Problem - Drug expenses have become a significant item in household and government budgets around the world as more innovative and pricey biotech...